Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PBSCT for Lymphoma
NCT00345865Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Aug 2005
- Primary completion
- Jun 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous peripheral blood stem cell in non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL), sponsored by Masonic Cancer Center. Started Aug 2005; status: completed.
02
Drugs
autologous peripheral blood stem cell
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00345865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345865.